NASDAQ:OPRX OptimizeRx (OPRX) Stock Price, News & Analysis $7.54 -0.27 (-3.46%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$7.37▼$7.8150-Day Range$7.53▼$11.2352-Week Range$6.92▼$16.65Volume97,200 shsAverage Volume126,657 shsMarket Capitalization$138.13 millionP/E RatioN/ADividend YieldN/APrice Target$14.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get OptimizeRx alerts: Email Address OptimizeRx MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.80 Rating ScoreUpside/Downside92.3% Upside$14.50 Price TargetShort InterestBearish5.93% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.33) to ($0.28) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.29 out of 5 starsComputer And Technology Sector495th out of 594 stocksBusiness Services, Not Elsewhere Classified Industry80th out of 91 stocks 3.4 Analyst's Opinion Consensus RatingOptimizeRx has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 4 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageOptimizeRx has only been the subject of 4 research reports in the past 90 days.Read more about OptimizeRx's stock forecast and price target. Previous Next 1.0 Short Interest Percentage of Shares Shorted5.93% of the float of OptimizeRx has been sold short.Short Interest Ratio / Days to CoverOptimizeRx has a short interest ratio ("days to cover") of 7.9.Change versus previous monthShort interest in OptimizeRx has recently increased by 1.00%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldOptimizeRx does not currently pay a dividend.Dividend GrowthOptimizeRx does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for OPRX. Previous Next 1.8 News and Social Media Coverage News SentimentOptimizeRx has a news sentiment score of 0.23. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.49 average news sentiment score of Computer and Technology companies.MarketBeat Follows2 people have added OptimizeRx to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, OptimizeRx insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 4.40% of the stock of OptimizeRx is held by insiders.Percentage Held by Institutions76.47% of the stock of OptimizeRx is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about OptimizeRx's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for OptimizeRx are expected to grow in the coming year, from ($0.33) to ($0.28) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of OptimizeRx is -7.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of OptimizeRx is -7.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioOptimizeRx has a P/B Ratio of 1.08. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about OptimizeRx's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Timothy SykesTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…Click here to see a unique election-year trade About OptimizeRx Stock (NASDAQ:OPRX)OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.Read More OPRX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart OPRX Stock News HeadlinesAugust 12, 2024 | finance.yahoo.comOptimizeRx Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues LagAugust 11, 2024 | finance.yahoo.comEarnings Release: Here's Why Analysts Cut Their OptimizeRx Corporation (NASDAQ:OPRX) Price Target To US$15.79September 7, 2024 | Behind the Markets (Ad)⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.August 9, 2024 | seekingalpha.comOptimizeRx Corporation (OPRX) Q2 2024 Earnings Call TranscriptAugust 9, 2024 | markets.businessinsider.comOptimizeRx Maintains Buy Rating: Robust Sales Pipeline and Improved Operational Efficiency Signal Strong Future GrowthAugust 9, 2024 | msn.comOptimizeRx Corporation (NASDAQ:OPRX) Q2 2024 Earnings Call TranscriptAugust 8, 2024 | investorplace.comOPRX Stock Earnings: OptimizeRx Beats EPS, Misses Revenue for Q2 2024August 8, 2024 | finance.yahoo.comInstitutional investors may adopt severe steps after OptimizeRx Corporation's (NASDAQ:OPRX) latest 24% drop adds to a year lossesSeptember 7, 2024 | Deal Maker (Ad)The solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post. With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.August 6, 2024 | finance.yahoo.comOptimizeRx Corporation (OPRX)July 25, 2024 | globenewswire.comOptimizeRx Sets Second Quarter 2024 Conference Call for August 8, 2024 at 4:30 p.m. ETJuly 23, 2024 | globenewswire.comOptimizeRx Delivers AI-Guided Privacy-Compliant Platform for Pharmaceutical Brand Marketing Amid Evolving Consumer Privacy LegislationJuly 15, 2024 | globenewswire.comOptimizeRx Demonstrates Measurable Script Lift for a Major Depressive Disorder Brand Targeting Physicians of Hard-to-Reach PatientsJune 20, 2024 | globenewswire.comNew White Paper Highlights How Closing the Health Information Gap Between Doctors and Patients Improves Life Science Marketing & Adds Value to Clinical ConversationsMay 15, 2024 | finanznachrichten.deOptimizeRx Corporation: OptimizeRx Reports First Quarter 2024 Financial ResultsMay 15, 2024 | marketwatch.comOptimizeRx Shares Rise 23% on 1Q Revenue Beat, FY GuidanceMay 15, 2024 | markets.businessinsider.comStifel Nicolaus Reaffirms Their Buy Rating on OptimizeRx (OPRX)May 15, 2024 | msn.comOptimizeRx Corporation (NASDAQ:OPRX) Q1 2024 Earnings Call TranscriptSee More Headlines Receive OPRX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for OptimizeRx and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/08/2024Today9/07/2024Next Earnings (Estimated)11/04/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorComputer and Technology Industry Business services, not elsewhere classified Sub-IndustryBusiness Services Current SymbolNASDAQ:OPRX CUSIPN/A CIK1448431 Webwww.optimizerx.com Phone(248) 651-6568Fax248-453-5529Employees100Year FoundedN/APrice Target and Rating Average Stock Price Target$14.50 High Stock Price Target$18.50 Low Stock Price Target$11.00 Potential Upside/Downside+92.3%Consensus RatingModerate Buy Rating Score (0-4)2.80 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)($1.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-17,570,000.00 Net Margins-21.53% Pretax Margin-31.60% Return on Equity-5.97% Return on Assets-4.42% Debt Debt-to-Equity Ratio0.27 Current Ratio3.07 Quick Ratio3.07 Sales & Book Value Annual Sales$71.52 million Price / Sales1.93 Cash FlowN/A Price / Cash FlowN/A Book Value$6.97 per share Price / Book1.08Miscellaneous Outstanding Shares18,320,000Free Float17,466,000Market Cap$138.13 million OptionableOptionable Beta1.27 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. William J. Febbo (Age 55)CEO & Director Comp: $863.15kMr. Stephen L. Silvestro (Age 46)President Comp: $591.62kMr. Edward Stelmakh C.M.A. (Age 58)M.B.A., CFO & COO Comp: $626.74kMr. Andrew Jacob D'SilvaSenior Vice President of Corporate FinanceKey CompetitorsASAPNASDAQ:WTRHLimelight NetworksNASDAQ:LLNWWilldan GroupNASDAQ:WLDNSohu.comNASDAQ:SOHUOmniAbNASDAQ:OABIView All CompetitorsInsiders & InstitutionsFirst Light Asset Management LLCBought 89,377 shares on 8/14/2024Ownership: 10.000%Marshall Wace LLPBought 45,748 shares on 8/14/2024Ownership: 0.250%Squarepoint Ops LLCBought 28,153 shares on 8/14/2024Ownership: 0.154%Divisadero Street Capital Management LPSold 256,987 shares on 8/13/2024Ownership: 7.203%Blair William & Co. ILSold 138,816 shares on 8/12/2024Ownership: 3.524%View All Insider TransactionsView All Institutional Transactions OPRX Stock Analysis - Frequently Asked Questions How have OPRX shares performed this year? OptimizeRx's stock was trading at $14.31 at the beginning of 2024. Since then, OPRX shares have decreased by 47.3% and is now trading at $7.54. View the best growth stocks for 2024 here. How were OptimizeRx's earnings last quarter? OptimizeRx Co. (NASDAQ:OPRX) announced its quarterly earnings data on Thursday, August, 8th. The company reported ($0.14) EPS for the quarter, beating the consensus estimate of ($0.25) by $0.11. The business had revenue of $18.81 million for the quarter, compared to the consensus estimate of $20.47 million. OptimizeRx had a negative net margin of 21.53% and a negative trailing twelve-month return on equity of 5.97%. Who are OptimizeRx's major shareholders? Top institutional investors of OptimizeRx include First Light Asset Management LLC (10.00%), Divisadero Street Capital Management LP (7.20%), Blair William & Co. IL (3.52%) and Rice Hall James & Associates LLC (2.72%). Insiders that own company stock include William J Febbo, James Paul Lang, Marion Odence-Ford, Stephen L Silvestro, Edward Stelmakh, Ellen O'connor Vos, Patrick D Spangler, Miriam J Paramore and Douglas P Baker. View institutional ownership trends. How do I buy shares of OptimizeRx? Shares of OPRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of OptimizeRx own? Based on aggregate information from My MarketBeat watchlists, some other companies that OptimizeRx investors own include InterDigital (IDCC), Bank of Hawaii (BOH), NVIDIA (NVDA), STAG Industrial (STAG), Etsy (ETSY), Marvell Technology (MRVL) and Trade Desk (TTD). This page (NASDAQ:OPRX) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredThese 5 stocks could soar after November 4thHow to Trade this Crazy Election Year? Simple – Just Focus on These 5 stocks… Now available – a free report...StockEarnings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OptimizeRx Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share OptimizeRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OPRX Stock Alerts